187 related articles for article (PubMed ID: 8915137)
1. Measurement of disease activity and outcome in atopic dermatitis.
Finlay AY
Br J Dermatol; 1996 Oct; 135(4):509-15. PubMed ID: 8915137
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P.
Hon KL; Lam MC; Wong KY; Leung TF; Ng PC
Br J Dermatol; 2007 Nov; 157(5):922-5. PubMed ID: 17725670
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
Yamaguchi J; Aihara M; Kobayashi Y; Kambara T; Ikezawa Z
J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
[TBL] [Abstract][Full Text] [Related]
4. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.
Hachisuka J; Takeuchi S; Kido M; Fukiwake N; Furue M
Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422
[TBL] [Abstract][Full Text] [Related]
5. Lesson from performing SCORADs in children with atopic dermatitis: subjective symptoms do not correlate well with disease extent or intensity.
Hon KL; Leung TF; Wong Y; Fok TF
Int J Dermatol; 2006 Jun; 45(6):728-30. PubMed ID: 16796637
[TBL] [Abstract][Full Text] [Related]
6. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score.
Oranje AP; Glazenburg EJ; Wolkerstorfer A; de Waard-van der Spek FB
Br J Dermatol; 2007 Oct; 157(4):645-8. PubMed ID: 17714568
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis.
Giordano-Labadie F; Cambazard F; Guillet G; Combemale P; Mengeaud V
J Dermatolog Treat; 2006; 17(2):78-81. PubMed ID: 16766330
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal wrist movements are correlated with objective clinical scores and plasma chemokine levels in children with atopic dermatitis.
Hon KL; Lam MC; Leung TF; Kam WY; Lee KC; Li MC; Fok TF; Ng PC
Br J Dermatol; 2006 Apr; 154(4):629-35. PubMed ID: 16536804
[TBL] [Abstract][Full Text] [Related]
9. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
10. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
Shaw M; Morrell DS; Goldsmith LA
Pediatr Dermatol; 2008; 25(1):19-24. PubMed ID: 18304147
[TBL] [Abstract][Full Text] [Related]
11. Treatment of atopic dermatitis with the xenon chloride excimer laser.
Baltás E; Csoma Z; Bodai L; Ignácz F; Dobozy A; Kemény L
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):657-60. PubMed ID: 16836491
[TBL] [Abstract][Full Text] [Related]
12. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.
Olivry T; Marsella R; Iwasaki T; Mueller R;
Vet Dermatol; 2007 Apr; 18(2):78-86. PubMed ID: 17355421
[TBL] [Abstract][Full Text] [Related]
13. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis.
Baron SE; Morris PK; Dye L; Fielding D; Goulden V
Br J Dermatol; 2006 May; 154(5):942-9. PubMed ID: 16634899
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and problems associated with using a wet-wrap garment for children with severe atopic dermatitis.
Hon KL; Wong KY; Cheung LK; Ha G; Lam MC; Leung TF; Chow CM; Tang YM; Luk NM; Leung AK
J Dermatolog Treat; 2007; 18(5):301-5. PubMed ID: 17852642
[TBL] [Abstract][Full Text] [Related]
15. Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis.
Lee CH; Chuang HY; Shih CC; Jong SB; Chang CH; Yu HS
Br J Dermatol; 2006 Jun; 154(6):1100-7. PubMed ID: 16704640
[TBL] [Abstract][Full Text] [Related]
16. Quality of life of children with atopic dermatitis and their families.
McKenna SP; Doward LC
Curr Opin Allergy Clin Immunol; 2008 Jun; 8(3):228-31. PubMed ID: 18560297
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris - a prospective study.
Schmitt J; Heese E; Wozel G; Meurer M
Dermatology; 2007; 214(1):68-76. PubMed ID: 17191051
[TBL] [Abstract][Full Text] [Related]
18. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
[TBL] [Abstract][Full Text] [Related]
19. Measuring atopic eczema severity visually: which variables are most important to patients?
Charman CR; Venn AJ; Williams H
Arch Dermatol; 2005 Sep; 141(9):1146-51; discussion 1151. PubMed ID: 16172312
[TBL] [Abstract][Full Text] [Related]
20. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
